We have 5 of 29 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Experimental evidence is provided supporting ISO as a potential therapeutic agent for vascular cognitive impairment by dose-dependently improving cognitive function and attenuated demyelination in white matter regions of BCAS mice.
Multiple sclerosis (MS) is an incurable and progressive inflammatory disease of the central nervous system (CNS) characterized by inflammatory demyelination, chronic axonal damage, and neurodegeneration. Carabrone (CA), a sesquiterpene lactone from the traditional Chinese herb Carpesium abrotanoides L., demonstrates di...
Microglia-targeted RIOK3 knockdown reduced infarct volume, improved early neurological and sensorimotor outcomes, preserved microglial process complexity, and reduced post-ischemic inflammation, and highlight the RIOK-YBX1 axis as a potential therapeutic target for ischemic stroke.
LILRB4 attenuates ischemic brain injury by suppressing STING/RIPK3‐mediated microglial necroptosis and neuroinflammation, emphasizing its significance as a potential neuroprotective therapy.
Results indicate that carabrone might act as a modulator of NLRP3 inflammasome activation across multiple inflammatory disease contexts.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.
